Sep 6, 2024, 09:00 | Blog

Updates in Immunotherapy for Cutaneous Sarcomas with Maurício Ribeiro at Sírio-Libanês Hospital Grand Rounds

Maurício Ribeiro posted on X: "Glad to have had the opportunity to discuss updates in…

Sep 2, 2024, 19:15 | Insight

Patrick Hwu: How does anti-CTLA-4 and anti-PD-1 combination work mechanistically?

Patrick Hwu shared a post on LinkedIn: “The combination of anti-CTLA-4 and anti-PD-1 antibodies is…

Sep 1, 2024, 10:46 | Insight

Article of the day, September 1st, suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…

Aug 30, 2024, 12:14 | Stories

Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention

Heman Bekele, a 14-year-old from Virginia, developed a bar of soap called Skin Cancer Treating…

Aug 30, 2024, 10:39 | Insight

Article of the day, August 30th, suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…

Aug 29, 2024, 15:37 | Career

Proposals for Team Science Award and Established Investigator Award for Pediatric Melanoma - St. Baldrick's Foundation

St. Baldrick's Foundation shared on LinkedIn: "In partnership with the Melanoma Research Alliance, we’re excited…

Aug 28, 2024, 05:03 | Insight

Individualized cancer therapy boosts immune activity - Mass General Cancer Center

Mass General Cancer Center shared a post on X: “A study led by researchers at…

Aug 26, 2024, 21:02 | Blog

Francesco Schettini: NGS of Actionable Genomic Alterations in Solid Tumors

Francesco Schettini, Medical Oncologist at the Breast Unit of the Hospital Clinic of Barcelona, posted…

Aug 26, 2024, 20:20 | Blog

Tanja Obradovic: Some points of interest from the Relativity-104 study

Tanja Obradovic shared on LinkedIn: "Opdualag, a cocktail of anti Lag-3 (relatlimab) and anti PD1…

Aug 23, 2024, 06:22 | Blog

Highlights from the 2024 Seattle Cellular Therapy Summit

The 2024 Seattle Cellular Therapy Summit will feature leading experts who will provide a detailed…

Aug 22, 2024, 17:45 | Dialogues

Beyond the Cancer Diagnosis: Dialogue with Dr. Alberto Costa, Hosted by Adrian Pogacian

In this new episode of ‘Beyond the Cancer Diagnosis’, Adrian Pogacian underlines the importance of…

Aug 22, 2024, 13:30 | Blog

Danielle Fournier: Content Experts Needed for the ONS Biomarker Database

Danielle Fournier, Advanced Practice Registered Nurse in the Department of Thoracic and Cardiovascular Surgery at…

Aug 22, 2024, 04:59 | Blog

Honoring Jeff Weber, a giant in the field of oncology

Jeffrey S. Weber, MD, PhD, a 2016 Giants of Cancer Care awardee in Melanoma, passed…

Aug 21, 2024, 14:43 | Blog

Science Saturday of anti-LAG-3 and anti-PD1 for advance melanoma with Patrick Hwu

Patrick Hwu shared a post on X: "The combination of anti-LAG-3 and anti-PD1 antibodies is US…

Aug 21, 2024, 14:16 | Blog

EORTC - Understanding long-term quality of life after completion of an adjuvant treatment for melanoma

EORTC - European Organisation for Research and Treatment of Cancer shared on LinkedIn: " Have you…

Aug 21, 2024, 14:03 | Blog

$3 million research grant to Dana-Farber Cancer Institute and UT Health San Antonio to study BRCA therapy

Dana-Farber Cancer Institute shared on LinkedIn: "Scientists at Dana-Farber's Center for BRCA and Related Genes in…

Aug 17, 2024, 12:25 | Blog

Oncoinfluencers to Follow on Social Media: Dr. Julia Lai-Kwon

We are excited to spotlight Dr. Julia Lai-Kwon, a prominent figure in the oncology community,…

Aug 16, 2024, 19:45 | Insight

Jarushka Naidoo: SYK signature predicts irAEs from adjuv ICI in melanoma

Jarushka Naidoo shared a post on X: "SYK signature predicts irAEs from adjuv ICI in melanoma…

Aug 14, 2024, 13:06 | Blog

Jennifer Marks: Treatment of melanoma from ASCO guidelines

Jennifer Marks, Thoracic Oncologist at Georgetown Lombardi, shared a post on X: “Treatment of melanoma…

Aug 11, 2024, 12:43 | Blog

Oncology Brothers: Melanoma Treatment Algorithm with Allison Betof Warner

Rahul Gosain posted on LinkedIn: "Melanoma: with Allison Betof Warner we the SoC for early, locally…

Aug 11, 2024, 02:13 | Societies

12 Posts Not To Miss From Day 3 of ASCOBT24!

This Year the ASCO Breakthrough (ASCOBT24) was held in Yokohama, Japan from 8th to 10th of…

Aug 9, 2024, 12:57 | Insight

Tony Cillo: Excited to share our paper on anti-PD1+anti-LAG3 therapy in melanoma

Tony Cillo, Assistant professor in the Department of Immunology at the University of Pittsburgh. "Excited…

Aug 9, 2024, 09:25 | Blog

Jessica Plowman: For the first time, I’m done and out of school

Jessica Plowman posted on LinkedIn: "Last week I presented my final project of my master’s…

Aug 7, 2024, 16:37 | Blog

2024 ASCO Breakthrough Featured Voices

The ASCO Breakthrough conference, hosted by the American Society of Clinical Oncology (ASCO), is a…

Jul 26, 2024, 19:52 | Blog

Georgina Long: Beautiful Tasmania with Australian of the Year Awards spreading message of sun safety to kids

Georgina Long shared on X: "Beautiful Tasmania with Australian of the Year Awards. Spreading message…

Jul 25, 2024, 00:43 | Blog

Aaron Tallent: A new standard is poised to transform melanoma care

Aaron Tallent, Co-host of the Loaded Goat Podcast, shared on X: "A new standard is…

Jul 22, 2024, 07:49 | Blog

Tian Zhang: Best of ASCO Dallas 2024

Best of ASCO, an Official Annual Meeting Review of the American Society of Clinical Oncology…

Jul 21, 2024, 12:10 | Blog

invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma

invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…

Jul 19, 2024, 12:57 | Blog

Ahmad Tarhini: Important implications for drug development targeting the microbiome

Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute, shared…

Jul 19, 2024, 04:23 | Opinion

Dr. Lynn Schuchter on the vital work for Skin and Melanoma Cancers

Brenda Brody, Senior Vice President of Strategy/Client Services at PineRock, shared a post on LinkedIn…

Jul 17, 2024, 23:34 | Blog

What Sapna Patel hopes to bring to the CU Cancer Center

University of Colorado Cancer Center shared on LinkedIn: "'I’m so thrilled to be here,' says Sapna…

Jul 16, 2024, 15:33 | Blog

Latest advancements and research changing the landscape of melanoma - Conquer Cancer, the ASCO Foundation

Conquer Cancer, the ASCO Foundation shared on LinkedIn: "True or false? We're learning all about the…

Jul 15, 2024, 09:22 | Blog

Craig Bunnell: My 10th Pan-Mass Challenge ride

Craig Bunnell, Chief Medical Officer at Dana-Farber Cancer Institute, shared on LinkedIn: "It's that time of year…

Jul 11, 2024, 12:56 | Blog

Patrick Hwu: Dangers of melanoma

Patrick Hwu shared a post on X: . "Did you know that a majority of…

Jul 9, 2024, 08:38 | Insight

Maria Babak: FDA approval to lifileucel for advanced melanoma offers hope to those with limited options

Maria Babak shared a post by The Babak Lab on LinkedIn, adding: “This is a…

Jul 8, 2024, 05:44 | Insight

Sapna Patel: An important pathway in cancer signaling, including melanoma

The Video Journal of Oncology (VJOncology) shared on LinkedIn: "New from ASCO2024: Phase I trial…

Jul 1, 2024, 01:56 | Blog

Richard Scolyer: The Melanoma Institute Australia team remains committed to reach zero deaths from melanoma

Richard Scolyer shared a post on X: "The Melanoma Institute Australia team had a very…

Jun 27, 2024, 13:53 | Insight

ESO refresher course in melanoma surgery

European School of Oncology (ESO) shared a post on LinkedIn: “Are you interested in melanoma?…

Jun 25, 2024, 14:38 | Insight

New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results

Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results …

Jun 25, 2024, 04:14 | Blog

Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma at ecancer - Sarah Cannon Research Institute

Sarah Cannon Research Institute shared on LinkedIn: "Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma…

Jun 25, 2024, 02:05 | Blog

Arif Kamal: Some of the most practice-changing updates that affect cancer care today

Arif Kamal shared on LinkedIn: , "This year's American Society of…

Jun 24, 2024, 12:07 | Blog

Neoadjuvant treatment in stage III melanoma

Georgina Long shared on X: "Another fantastic collaboration - Peter Mac Cancer Centre and Melanoma Institute…

Jun 24, 2024, 10:34 | Insight

Susanna Greer: Opening the door to new treatments for cancer patients

Susanna Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared on LinkedIn:…

Jun 23, 2024, 07:51 | Blog

Patrick Hwu: Ryan Sullivan is a leader in Melanoma research

Patrick Hwu shared on X: . "So thrilled to see…

Jun 22, 2024, 03:59 | Insight

Shahrin Ahmed: The results of a melanoma jab trial were extremely impressive

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: “The results of a…

Jun 17, 2024, 18:08 | Blog

Trish Boh: We gathered at the St. Elizabeth Healthcare Cancer Centers to observe National Cancer Survivors Day

Trish Boh, Executive Secretary to Executive Medical Director of Oncology Services and Directors at St.…

Jun 16, 2024, 15:16 | Insight

Cost of care discussions in medical records of patient with advanced NSCLC and melanoma - ACS Journal Cancer

Robin Yabroff, Scientific Vice President at the American Cancer Society, recently shared a post by…

Jun 12, 2024, 17:27 | Blog

Winette van der Graaf: Two papers in the New England Journal of Medicine in one week

Winette van der Graaf shared a post on their LinkedIn: ''Extremely proud and grateful for…

Jun 10, 2024, 16:23 | Blog

Laura Bobolts: Here are my top 3 studies from ASCO2024

Laura Bobolts, Senior Vice President, Clinical Strategy and Growth at OncoHealth, posted on LinkedIn: "ASCO2024 is…

Jun 6, 2024, 06:30 | Blog

Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management

Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute,…

Jun 6, 2024, 02:56 | Blog

Results from the Phase 3 NADINA Clinical Trial - Melanoma Institute Australia

Melanoma Institute Australia posted on LinkedIn: "Heralded as a cancer treatment revolution, the pre-surgery (neoadjuvant)…

Jun 5, 2024, 13:41 | Societies

Allison Betof Warner: Headed home from a hugely successful ASCO24

Allison Betof Warner,Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford Cancer…

Jun 5, 2024, 10:01 | Insight

Gergely Szótér: The future of cancer treatment is here

Gergely Szótér, Strategic Partner Business Analyst at Avantor, recently shared a post on X: "The…

Jun 5, 2024, 04:04 | Drugs

Jon Wigginton: Very exciting phase 3 data regarding stage 3 melanoma

Jon Wigginton, President of Research and Development at Bright Peak Therapeutics, shared on LinkedIn: “NEJM…

Jun 4, 2024, 13:13 | Insight

Tanja Obradovic: NADINA trial making history at ASCO2024 plenary session

Tanja Obradovic shared on LinkedIn: . "NADINA trial making history today at ASCO2024 plenary session.…

Jun 4, 2024, 03:08 | Societies

ASCO24 Day 3 Highlights by The Oncology Brothers

The Oncology Brothers shared on X: "1. DB06 TDxD HR+ metastatic breast cancer (mBC) 2.…

May 31, 2024, 22:07 | Insight

Ahmad Tarhini: Employing a machine learning framework to molecular data from patients with melanoma

Ahmad Tarhini, Director of Cutaneous Clinical and Translational Research at Moffitt Cancer Center, shared on…

May 30, 2024, 15:35 | Blog

Patrick Hwu: Chat with Lilit Karapetyan about her work with TIL therapy for melanoma

Rick Buck Chief Communications Officer/Vice President of Communications and Public Relations at AACR, shared a…

May 29, 2024, 11:10 | Blog

The future of immunotherapy in melanoma and beyond on the ASCO Daily News Podcast

ASCO made the following post on X: "Diwakar Davar & Jason Luke of UPMC Hillman Cancer…

May 29, 2024, 10:00 | Blog

Jason Luke: Discussing ASCO24 abstracts with Diwakar Davar

Jason Luke, Associate Professor at the University of Pittsburgh, shared a post on X: "Appreciated…

May 29, 2024, 08:24 | Blog

Melanoma Institute Australia CEO Matthew Browne received a cheque from Tour de Cure Australia for funds raised at the 2024 Long Lunch

Melanoma Institute Australia shared on LinkedIn: "Today our MIA CEO Matthew Browne (2nd from left)…

May 29, 2024, 02:50 | Blog

Shahrin Ahmed raises awareness on Melanoma skin cancer cases rising in UK

Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, made the following post on X: “Melanoma skin…

May 28, 2024, 11:47 | Insight

Shahrin Ahmed: The progression of melanoma can be rapid

Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, made the following post on X: "The location…

May 26, 2024, 12:17 | Societies

Tarek Haykal: My selection from ASCO2024 abstracts

Tarek Haykal, Assistant Professor and Medical Oncologist at the Ohio State University, shared a post…

May 26, 2024, 08:41 | Blog

We are pleased to present new data at ASCO24 - Natera Oncology

Natera Oncology shared a post on X: “We are pleased to present new data at…

May 25, 2024, 13:26 | Societies

MD Anderson Cancer Center researchers will showcase the latest breakthroughs in cancer care at the 2024 ASCO Annual Meeting

MD Anderson Cancer Center shared on LinkedIn: "MD Anderson researchers will showcase the latest breakthroughs…

May 25, 2024, 10:20 | Drugs

An ASCO 24 Educational Session will review accelerated approval of lifileucel in advanced melanoma

ASCO (American Society of Clinical Oncology) shared on X: "Accelerated approval of lifileucel in advanced melanoma…

May 23, 2024, 13:04 | Blog

Tom Powles on the NADINA trial

Tom Powles, Director of Barts Cancer Center, shared a post on X: "The NADINA trial…

May 22, 2024, 10:51 | Blog

Shahrin Ahmed: Skin Cancer Awareness Month is devoted to shining the spotlight on the most common cancer in the North America

Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, made the following post on X: "Occurring…

May 22, 2024, 09:36 | Blog

Marco Donia: Does participation in Cancer Clinical Trials improve survival outcomes on its own?

Marco Donia, made the following post on LinkedIn: "Does participation in Cancer Clinical Trials improve survival…

May 22, 2024, 08:39 | Blog

Tanja Obradovic: ASCO just published guidelines for germline genetic testing panels

Tanja Obradovic shared on LinkedIn: "Great service to public and oncology community as ASCO just published…

May 22, 2024, 04:25 | Blog

Timothée Olivier: One of the most important and practice-changing piece this year

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X…

May 21, 2024, 12:16 | Cancer Types

Melanoma in Adults: What patients should know about

What is Melanoma ? Melanoma is a type of skin cancer that originates in the melanocytes, the cells responsible…

May 19, 2024, 14:01 | Insight

Arielle Elkrief: Excited to launch this pan Canadian phase 2 RCT of FMT and ICI in melanoma

Arielle Elkrief, Assistant Professor and Principal Scientist at University of Montreal, shared a post by…

May 19, 2024, 09:28 | Blog

World’s largest randomized clinical trials using fecal microbiota transplantation for advanced melanoma- Canadian Cancer Society

Canadian Cancer Society shared a post on LinkedIn: “An estimated 11,300 Canadians are expected to…

May 18, 2024, 14:15 | Insight

Tracey O’Brien: Melanoma Institute Australia is moving the dial in understanding and personalizing treatment melanoma for AYA

Tracey O’Brien shared a post by Melanoma Institute Australia on LinkedIn, adding: "The most common…

May 16, 2024, 16:51 | Insight

10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily

In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…

May 10, 2024, 10:27 | Opinion

Piotr Wysocki: FDG PET can predict response to immunotherapy in melanoma patients

Piotr Wysocki recently posted on LinkedIn: "Anderson TM et al. published the results of a study…

May 9, 2024, 10:45 | Positive

See what our post-Journal Club happy hour looks like! - Roswell Park Hematology/Oncology Fellowship Program

The Roswell Park Hematology/Oncology Fellowship Program shared on X: "See what our post-Journal Club happy…

May 6, 2024, 07:29 | Insight

Center for Cancer Immune Therapy - Molecular patterns of resistance to immune checkpoint blockade in melanoma

Center for Cancer Immune Therapy shared on LinkedIn: "Molecular patterns of resistance to immune checkpoint…

May 4, 2024, 11:25 | Blog

Ines Brecht: EU-funded MELCAYA project

Ines Brecht, Pediatric Oncologist at the University Children's Hospital Tuebingen, shared a post by MELCAYA…

Apr 29, 2024, 08:43 | Career

Canadian Cancer Society congratulates Bertrand Routy, who won the Distinction Heartfelt Award of the College of Physicians of Quebec

Canadian Cancer Society shared a post on LinkedIn: "Congratulations to Dr. Bertrand Routy, a hematologist-oncologist…

Apr 28, 2024, 11:04 | Blog

Ana I. Velázquez Mañana: ASCO24 abstract titles are out! Exciting Plenary Session, specially for LCSM community

Ana I. Velázquez Mañana shared on X/Twitter: “ASCO24 abstract titles are out! Exciting Plenary Session, specially…

Apr 20, 2024, 06:35 | Career

Sara Vergara: I’m happy to share that I’ve been promoted to Director of US Medical Affairs - Hematology (Myeloid) at Bristol Myers Squibb

Sara Vergara shared on LinkedIn: "I’m happy to share that I’ve been promoted to Director…

Apr 11, 2024, 15:57 | Insight

Marco Donia: Therapeutic Cancer Vaccines - update in Melanoma

Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…

Apr 10, 2024, 08:46 | Societies

While at AACR24, Ahmad Tarhini joined Patrick Hwu to discuss the latest in melanoma research and biomarker clinical trials - Moffitt Cancer Center

Moffitt Cancer Center shared a post on LinkedIn: “While at AACR24, Ahmad Tarhini joined Patrick…

Apr 9, 2024, 15:45 | Insight

Review on the long-term effects of Immune Checkpoint Inhibitors - DKFZ German Cancer Research Center

Quoting DKFZ German Cancer Research Center on LinkedIn: "Review on the long-term effects of Immune…

Apr 8, 2024, 20:03 | Drugs

Allison Betof Warner: Our Melanoma and Cell Therapy teams at Stanford Cancer Institute performed the first commercial lifileucel infusion

Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…

Apr 7, 2024, 23:34 | Blog

Manmeet Ahluwalia: Look forward to host the Second Miami Cancer Institute Precision Oncology Symposium

Manmeet Ahluwalia, Chief of Medical Oncology at Miami Cancer Institute, shared on LinkedIn: “Look forward…

Apr 5, 2024, 17:16 | Blog

Joal Beane: Congrats to my mentee Hayley Dunlop for her work on disparities in the care of patients with melanoma

Joal Beane, Surgical Oncologist, Specializing in the Treatment of Melanoma and Sarcoma, made the following…

Apr 2, 2024, 12:20 | Insight

Ankit Mangla: Our analysis of data from neoadjuvant IO trials in melanoma has been published in JAMA Oncology

Ankit Mangla, Sarcoma and Cutaneous Oncology Specialist at the Seidman Cancer Center, shared a post…

Mar 31, 2024, 08:44 | Blog

UCLA Health Jonsson Comprehensive Cancer Center's presentation at the annual meeting of the American Association for Cancer Research (AACR)

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…

Mar 29, 2024, 15:11 | Blog

Research project involving melanoma treatment monitoring is now up for voting in STAT Madness - Brigham and Women's Hospital

Brigham and Women's Hospital shared on their LinkedIn page: "Natalie Artzi, PhD, is working on…

Mar 27, 2024, 21:58 | Blog

Annie Wong: Interesting discussions at the Melanoma and Skin Cancer Trials study concept workshop

Annie Wong, Consultant Medical Oncologist at Wellington Regional Hospital, shared a post on X: "Interesting…

Mar 13, 2024, 22:26 | Insight

Richard Scolyer: I spent time in Canberra to discuss important melanoma and skin cancer issues for all Australians

Richard Scolyer, Co-medical director at the Melanoma Institute Australia, and Cojoint professor at the University…

Mar 3, 2024, 05:48 | Blog

Check out the latest 'Ask the Expert' webinar hosted by Melanoma Research Foundation - Agenus

Agenus shared a post on LinkedIn: ''In case you missed it, check out the latest…

Feb 28, 2024, 12:14 | Blog

Michael Zinner: Congratulations to Naiara Fraga Braghiroli, who was recently honored by the Baptist Health Foundation at her installation as the Kalman Bass Endowed Chair in Skin Cancer

Feb 24, 2024, 17:10 | Blog

Bettina Ryll: How did we end up in a situation where we put clinical trials as a method before patients' lives?

Bettina Ryll, Founder of MPN Europe, shared on LinkedIn: "Working on my talk for the…

Feb 23, 2024, 17:44 | Drugs

Allison Betof Warner: The TIL team at Stanford Cancer Institute did our first surgical tumor harvest for AMTAGVI (lifileucel) this morning!

Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…

Feb 16, 2024, 06:19 | Opinion

Douglas Flora: I underwent a skin biopsy a few weeks ago that came with considerable anxiety with the specter of melanoma looming

Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on…